CD31 regulates metabolic switch in Treg migration attenuates rheumatoid arthritis

Abstract

CD31 (PECAM-1) plays a critical role in T cell migration, whilst its immunoreceptor tyrosine inhibitory motifs (ITIMs), Y663 and Y686, are recognised for their roles in endothelial function, the precise mechanism in regulating immune cell remains elusive. Here, we demonstrate that CD31 is essential for Treg migration. Upon ITIM engagement, CD31 activates and interacts with the protein tyrosine phosphatase SHP2. In vivo, CD31 Y663F gene transfer recapitulates the wild-type migration phenotype, driven by a metabolic switch to fructose utilisation under the regulation of the PFKFB3 gene. Conversely, the Y686F mutation impairs Tregs migration by disrupting both glycolysis and the switch to fructose metabolism, thus promoting the mitochondrial function via activation of the RNF111/OGT pathway. Our findings reveal a novel role for CD31 ITIMs in orchestrating a metabolic that is switch crucial for Treg migration. This understanding of CD31 polymorphisms and their impact on Treg migration offers potential therapeutic avenues for autoimmune diseases, particularly rheumatoid arthritis (RA).

Keywords

CD31 ITIMs / metabolic switch / PFKFB3 / RNF111/OGT pathway / Tregs migration

References

[1] Ma L, Cheung KCP, Kishore M, Nourshargh S, Mauro C, Marelli-Berg FM. CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo. J Immunol. 2012; 189: 4104-4111.

[2] Andreata F, Clément M, Benson RA, et al. CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation. Elife. 2023; 12: e84752.

[3] Kotschenreuther K, Yan S, Kofler DM. Migration and homeostasis of regulatory T cells in rheumatoid arthritis. Front Immunol. 2022; 13: 947636.

[4] Honing DY, Luiten RM, Matos TR. Regulatory T cell dysfunction in autoimmune diseases. Int J Mol Sci. 2024; 25: 7171.

[5] Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem. 1997; 272: 24868-24875.

[6] Miao J, Wang Di, Pang R, et al. Role of fructose in renal cell carcinoma progression. Discov Oncol. 2025; 16: 897.

[7] Cheung KCP, Fanti S, Mauro C, et al. Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming. Nat Commun. 2020; 11: 3595.

[8] Leibowitz A, Rehman A, Paradis P, Schiffrin EL. Role of T regulatory lymphocytes in the pathogenesis of high-fructose diet-induced metabolic syndrome. Hypertension. 2013; 61: 1316-1321.

[9] Lu Si, Zhao R, Han Y, et al. Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance. Clin Exp Med. 2024; 24: 219.

[10] Chang YH, Weng CL, Lin KI. O-GlcNAcylation and its role in the immune system. J Biomed Sci. 2020; 27: 57.

[11] Xu H, Wu L, Nguyen HH, et al. Arkadia-SKI/SnoN signaling differentially regulates TGF-β-induced iTreg and Th17 cell differentiation. J Exp Med. 2021; 218: e20210777.

[12] Lu Q, Zhang X, Liang T, Bai X. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Mol Med. 2022; 28: 115.

[13] Zhang Z, Salgado OC, Liu B, et al. An OGT-STAT5 axis in regulatory T cells controls energy and iron metabolism. Front Immunol. 2022; 13: 874863.

[14] Yan S, Kotschenreuther K, Deng S, Kofler DM. Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. Cell Mol Life Sci. 2022; 79: 533.

[15] Cicmil M, Thomas JM, Sage T, et al. Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases. J Biol Chem. 2000; 275: 27339-27347.

[16] Cheung KCp, Ma J, Wang Lu, et al. CD31 orchestrates metabolic regulation in autophagy pathways of rheumatoid arthritis. Pharmacol Res. 2024; 207: 107346.

[17] Newman DK, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood. 2001; 97: 2351-2357.

[18] Henshall TL, Jones KL, Wilkinson R, Jackson DE. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J Immunol. 2001; 166: 3098-3106.

[19] Ma T, Chen Y, Zhang F, Yang C-Y, Wang S, Yu X. RNF111-dependent neddylation activates DNA damage-induced ubiquitination. Mol Cell. 2013; 49: 897-907.

[20] Ge X, Peng X, Li M, Ji F, Chen J, Zhang D. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells. Pathol Res Pract. 2021; 225: 153580.

[21] Cheung K, Ma L, Wang G, et al. CD31 signals confer immune privilege to the vascular endothelium. Proc Natl Acad Sci U S A. 2015; 112: E5815-5824.

[22] Marabelle A, Kohrt H, Sagiv-Barfi I, et al. Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest. 2013; 123(6): 2447-2463.

[23] Chen Yi-M, Chang C-Yu, Chen H-H, et al. Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy. Arthritis Res Ther. 2018; 20: 268.

[24] Kishore M, Cheung KCP, Fu H, et al. Regulatory T cell migration is dependent on glucokinase-mediated glycolysis. Immunity. 2017; 47: 875-889.e810.

[25] Lee JY, Stevens RP, Pastukh VV, et al. PFKFB3 inhibits fructose metabolism in pulmonary microvascular endothelial cells. Am J Respir Cell Mol Biol. 2023; 69: 340-354.

[26] Su Q-Yi, Li H-C, Jiang X-J, et al. Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: insights into subsets, markers, and signaling pathways. Biomed Pharmacother. 2024; 174: 116440.

[27] Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and role of regulatory T cells in rheumatoid arthritis. Front Immunol. 2021; 12: 626193.

[28] Caruso P, Dunmore BJ, Schlosser K, et al. Identification of microRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2. Circulation. 2017; 136: 2451-2467.

[29] Koinuma D, Shinozaki M, Komuro A, et al. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J. 2003; 22: 6458-6470.

[30] Caligiuri G, Groyer E, Khallou-Laschet J, et al. Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler Thromb Vasc Biol. 2005; 25: 1659-1664.

[31] Fornasa G, Clement M, Groyer E, et al. A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res. 2012; 94: 30-37.

[32] Listì F, Candore G, Lio D, et al. Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur J Immunogenet. 2004; 31: 175-178.

[33] Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69: 1580-1588.

[34] Nakagawa T, Lanaspa MA, Millan IS, et al. Fructose contributes to the Warburg effect for cancer growth. Cancer Metab. 2020; 8: 16.

[35] Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020; 36: 2628-2629.

[36] Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013; 29: 1830-1831.

[37] Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021; 49: D545-d551.

[38] von Mering C, Jensen LJ, Snel B, et al. STRING: known and predicted protein–protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005; 33: D433-437.

[39] He Z, Shen S, Yi Y, et al. CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway. Am J Transl Res. 2023; 15: 2656-2675.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.